Imarc
Consulting Services
www.imarcgroup.com
US Diabetes Market Report: 2016 - 2020
Copyright Š 2016 International Market Analysis Research & Consulting (IMARC). All Rights Reserved
Imarc
About IMARC Group
Report Description
www.imarcgroup.com
The International Market Analysis Research and Consulting Group is a leading advisor on management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.
Imarc
Report Description and Highlights
Report Description
www.imarcgroup.com
US Diabetes Market 2016 – Trends, Demographical breakup, Diagnosis and Treatments and Forecasts IMARC’s new report “US Diabetes Market Report: 2016 - 2020” provides an analytical and statistical insight into the US diabetes market. The report provides both current and future trends in the prevalence, demographical breakup, diagnosis and treatment of diabetes in the United States. The research study serves as an exceptional tool to understand the epidemiology, market trends, therapeutic structure, competitive structure and the outlook of the US diabetes market. This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who are planning to foray into the US diabetes market in any form. What we have achieved in this report: Comprehensive situation analysis of the US diabetes epidemiology and its dynamics: Focus of the Analysis: • • • • • • •
Historical, current and future prevalence of diabetes in US Historical, current and future prevalence of type-1 and type-2 diabetes in US Historical, current and future prevalence of diabetes in the urban and rural regions in US Historical, current and future prevalence of diabetes among males and females in US Historical, current and future prevalence of diabetes among various age groups in US Historical, current and future diagnosis rates for diabetes in US Historical, current and future drug treatment rates for diabetes in US
Imarc
Report Description and Highlights
Report Description
www.imarcgroup.com
Comprehensive situation analysis of the US Oral Antidiabetics market and its dynamics: Focus of the Analysis: • • • •
Performance of the Oral Antidiabetics market in US Performance of key classes Performance of key players Market outlook
Comprehensive situation analysis of the US Insulin market and its dynamics: Focus of the Analysis: • • • •
Performance of the Insulin market in US Performance of key classes Performance of key players Market outlook
Imarc www.imarcgroup.com
US Diabetes Market
Imarc
Report Description and Highlights
Report Description
www.imarcgroup.com
Table of Contents 1 Research Methodology 2 Executive Summary 3 Diabetes Disease Overview 3.1 What is Diabetes? 3.2 Diabetes Diagnosis and Treatment 3.2.1 Diagnosis 3.2.2 Treatment 3.3 Diabetes Complications 4 Key Factors Driving the Diabetes Market in US 5 US Diabetes Epidemiology 5.1 Diabetes Population and Prevalence Rates 5.2 Population and Prevalence Rates by Diabetes Type (Type-1 and Type-2) 5.3 Population and Prevalence Rates by Region 5.4 Population and Prevalence Rates by Gender 5.5 Population and Prevalence Rates by Age Group 6 US Diabetes Market 6.1 Historical Market Trends 6.2 Market Outlook 6.3 Market Breakup by Segment 6.4 US Oral Antidiabetics Market 6.4.1 Historical Market Trends 6.4.2 Market Breakup by Class
Imarc
Report Description and Highlights
Report Description
www.imarcgroup.com
6.4.3 Market Shares of Key Players 6.4.4 Market Outlook 6.5 US Insulin Market 6.5.1 Historical Market Trends 6.5.2 Market Breakup by Class 6.5.3 Market Shares of Key Players 6.5.4 Market Outlook List of Figures Figure 3 1: The impact of Diabetes in the Human Body Figure 3 2: Diabetes Complications Figure 4 1: Global: Breakup of Diabetes Patients by Region, (in %) 2015 & 2035 Figure 4 2: US: Overweight & Obese Population* (in Million), 2010, 2015 & 2020 Figure 4 3: Body Mass Index and Relative risk of Type-2 Diabetes Figure 4 4: US: Breakup of Total Population by Age Groups (0-14, 15-64 & 65+), (in %) Figure 4 5: US: Diabetes Prevalence By Age Groups, (in %) Figure 5 1: US: Total Number of Diabetes Patients* (in 000), 2008-2015 Figure 5 2: US: Total Number of Diabetes Patients* Forecast (in 000), 2016-2020 Figure 5 3: US (Type1 & Type2): Total Number of Diabetes Patients* (in 000), 2008- 2015 Figure 5 4: US (Type1 & Type2): Total Number of Diabetes Patients* (in 000),2016-2020 Figure 5 5: US (Urban & Rural): Total Number of Diabetes Patients* (in 000), 2008 -2015 Figure 5 6: US (Urban & Rural): Total Number of Diabetes Patients* (in 000), 2016 - 2020
Imarc
Report Description and Highlights
Report Description
www.imarcgroup.com
Figure 5 7: US (Male & Female): Total Number of Diabetes Patients* (in 000), 2008 - 2015 Figure 5 8: US (Male & Female): Total Number of Diabetes Patients* (in 000), 2016 - 2020 Figure 5 9: US: Total Number of Diabetes Patients by Age Group (20-39), (40-59) & (60-79) (in 000), 2008 - 2015 Figure 5 10: US: Total Number of Diabetes Patients by Age Group (20-39), (40-59) & (60-79) (in 000), 2016 - 2020 Figure 6 1: US: Diabetes Drugs Market (in Million US$), 2008 - 2015 Figure 6 2: US: Diabetes Drug Market Forecast (in Million US$), 2016 - 2020 Figure 6 3: US: Diabetes Drugs Market: Breakup of Insulin and Oral Antidiabetics (in %), 2008- 2015 Figure 6 4: US: Diabetes Drugs Market Forecast: Breakup of Insulin and Oral Antidiabetics (in %), 2016 - 2020 Figure 6 5: US: Oral Antidiabetics Market: (in Million US$), 2008 - 2015 Figure 6 6: US: Oral Antidiabetics Market: Sales Share of Key Classes (in %), 2008 & 2015 Figure 6 7: US: Oral Anti-diabetics Market: Sales Share of Key Players (in %) Figure 6 8: US: Oral Antidiabetics Market: (in Million US$), 2016 - 2020 Figure 6 9: US: Oral Antidiabetics Market: Sales Share of Key Classes (in %), 2016 & 2020 Figure 6 10: US: Insulin Market, (in Million US$), 2008 - 2015 Figure 6 11: US: Breakup of Insulin Market by Class (in %) Figure 6 12: US: Insulin Market: Sales Share of Key Players (in %) Figure 6 13: US: Insulin Market Forecast (in Million US$), 2016 - 2020
Imarc
Report Description and Highlights
Report Description
www.imarcgroup.com
List of Tables Table 3 1: Diagnosis of Diabetes Table 4 1: Global: Diabetes Population Breakup by Country (in 000’s), 2015 & 2035 Table 4 2: US: Overweight &Obesity Statistics, 2010, 2015 & 2020 Table 4 3: US: Breakup of Total Population by Age Groups (0-14, 15-64 & 65+), (in Million) Table 5 1: US: Total Prevalence & Number of Diabetes Patients*, 2008, 2015 & 2020 Table 5 2: US (Type1 & Type2): Total Prevalence & Number of Diabetes Patients, 2008, 2015 & 2020 Table 5 3: US (Urban & Rural): Total Prevalence & Number of Diabetes Patients, 2008, 2015 & 2020 Table 5 4: US (Male & Female): Total Prevalence & Number of Diabetes Patients, 2008, 2015 & 2020 Table 5 5: Total Prevalence & Number of Diabetes Patients by Age Group (20-39), (40-59) & (60-79) (In Millions), 2008, 2015 & 2020
Imarc
Report Description and Highlights
Report Description
www.imarcgroup.com
To buy the complete report or to get a free sample, please contact:
IMARC Group Asia: Email: apac@imarcgroup.com Phone: +91-120-415-5099
IMARC Group North America: Email: america@imarcgroup.com Phone: +1-631-791-1145
IMARC Group Europe, Middle East & Africa: Email:ema@imarcgroup.com Phone: +44-702-409-7331
To know more please visit: http://www.imarcgroup.com/US-diabetes-market
Imarc
Report Description and Highlights
Report Description
www.imarcgroup.com
Š 2016 IMARC All Rights Reserved This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC). Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication. IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.
Contact Us
FOR MORE DETAILS Visit us at :
http://www.imarcgroup.com Stay With Us:
TELEPHONE: +91-120-4155099 E-MAIL: sales@imarcgroup.com